Literature DB >> 12226091

The TSC1 tumor suppressor hamartin interacts with neurofilament-L and possibly functions as a novel integrator of the neuronal cytoskeleton.

Luciana A Haddad1, Nicole Smith, Mark Bowser, Yo Niida, Vanishree Murthy, Charo Gonzalez-Agosti, Vijaya Ramesh.   

Abstract

Tuberous sclerosis complex, an autosomal dominant disease caused by mutations in either TSC1 or TSC2, is characterized by the development of hamartomas in a variety of organs. The proteins encoded by TSC1 and TSC2, hamartin and tuberin, respectively, associate with each other forming a tight complex. Here we show that hamartin binds the neurofilament light chain and it is possible to recover the hamartin-tuberin complex over the neurofilament light chain rod domain spanning amino acids 93-156 by affinity precipitation. Homologous rod domains in other intermediate filaments such as neurofilament medium chain, alpha-internexin, vimentin, and desmin are not able to bind hamartin. In cultured cortical neurons, hamartin and tuberin co-localize with neurofilament light chain preferentially in the proximal to central growth cone region. Interestingly, in the distal part of the growth cone hamartin overlaps with the ezrin-radixin-moesin family of actin binding proteins, and we have validated the interaction of hamartin with moesin. These results demonstrate that hamartin may anchor neuronal intermediate filaments to the actin cytoskeleton, which may be critical for some of the CNS functions of the hamartin-tuberin complex, and abolishing this through mutations in TSC1 or TSC2 may lead to certain neurological manifestations associated with the disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12226091     DOI: 10.1074/jbc.M207211200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

Review 1.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

Review 2.  The neurobiology of the tuberous sclerosis complex.

Authors:  Leah Marcotte; Peter B Crino
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

3.  Up-Regulation of microRNA-183 Promotes Cell Proliferation and Invasion in Glioma By Directly Targeting NEFL.

Authors:  Ze-You Wang; Jing Xiong; Shan-Shan Zhang; Jian-Jun Wang; Zhao-Jian Gong; Min-Hui Dai
Journal:  Cell Mol Neurobiol       Date:  2016-02-15       Impact factor: 5.046

Review 4.  Lymphangioleiomyomatosis: what do we know and what are we looking for?

Authors:  S Harari; O Torre; J Moss
Journal:  Eur Respir Rev       Date:  2011-03

Review 5.  Mechanism-based treatment in tuberous sclerosis complex.

Authors:  Kristina Jülich; Mustafa Sahin
Journal:  Pediatr Neurol       Date:  2013-12-05       Impact factor: 3.372

Review 6.  Mechanisms of neurocognitive dysfunction and therapeutic considerations in tuberous sclerosis complex.

Authors:  Peter Tsai; Mustafa Sahin
Journal:  Curr Opin Neurol       Date:  2011-04       Impact factor: 5.710

7.  miR-25 promotes glioblastoma cell proliferation and invasion by directly targeting NEFL.

Authors:  Gang Peng; Xianrui Yuan; Jian Yuan; Qing Liu; Minhui Dai; Chenfu Shen; Jianrong Ma; Yiwei Liao; Weixi Jiang
Journal:  Mol Cell Biochem       Date:  2015-07-26       Impact factor: 3.396

8.  NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth.

Authors:  Marianne F James; Sangyeul Han; Carolyn Polizzano; Scott R Plotkin; Brendan D Manning; Anat O Stemmer-Rachamimov; James F Gusella; Vijaya Ramesh
Journal:  Mol Cell Biol       Date:  2009-05-18       Impact factor: 4.272

9.  Tuberous sclerosis complex proteins control axon formation.

Authors:  Yong-Jin Choi; Alessia Di Nardo; Ioannis Kramvis; Lynsey Meikle; David J Kwiatkowski; Mustafa Sahin; Xi He
Journal:  Genes Dev       Date:  2008-09-15       Impact factor: 11.361

10.  Genetics and molecular biology of tuberous sclerosis complex.

Authors:  Valerio Napolioni; Paolo Curatolo
Journal:  Curr Genomics       Date:  2008-11       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.